Pfizer (PFE) to Decrease Stake in Haleon From 32% to 24%

Pfizer (PFE) plans to sell 630 million ordinary shares of the consumer health company Haleon (HLN) , which it owns, in an underwritten offering. The sale of 630 million ordinary shares should be worth around $2.5 billion. Additionally, per a previous plan approved by Haleon shareholders, Pfizer will sell some shares worth approximately$400 million (£315 million) directly to Haleon.Haleon was a consumer health joint venture (JV), an over-the-counter (OTC) medicines business, jointly created by Pfizer and GS ...